Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11464195.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epidermodysplasia verruciformis (EV) is an autosomal recessive disease characterized by the lifelong eruption of disseminated verrucae-like lesions. Numerous treatment modalities have been used to treat EV without benefit. Recently, retinoid and interferon therapies have been found to be of value in the treatment of EV. We present a case of EV that was treated with a combination of acitretin and interferon alfa-2a.
Medical subject headings
- Acitretin
- Antiviral Agents
- Epidermodysplasia Verruciformis
- Interferon-alpha
- Keratolytic Agents